Unicat
Unicat
Sex: F
Data Quality: 2 stars
MS: 10 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: moderate
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: moderate
Unicat
Female, 42 years
Two Rivers, WI
Primary Condition
MS and 2 more
Type
Relapsing-Remitting
First symptom
May 2002
Diagnosis
Jul 2002
See more
  1. Unicat
    star earnedstar earnedstar  notearned 2 stars
    lost a star May 18, 2012
  2. Unicat
    Updated outcome
    QOL
    • Good Social
    • Good Mental
    • Bad Physical
    completed the QOL survey for Mar 10, 2012 Mar 10, 2012
  3. Unicat
    MSRS
    64
    • Moderate Cognition
    • Mild Vision
    • Mild Speech
    • Moderate Swallowing
    • Mild Upper Limb
    • Moderate Walking
    • Moderate Sensation
    completed the MSRS survey for Mar 9, 2012 Mar 09, 2012
  4. Unicat
    Added
    Symptom Update
    • mild Vaginal dryness
    • none MS hug (tight chest or torso)
    • moderate Bowel problems
    • mild Bladder problems
    • mild Weight gain
    • moderate Swallowing difficulty (dysphagia)
    • See more
    updated heryour symptoms for Mar 7, 2012 Mar 07, 2012
    1 comment from other members. Sign up to see comments!
  5. Unicat
    New evaluation
    Phenazopyridine Treatment Evaluation
    • Efficacy for UTI (Urinary Tract Infection): Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate
    • Side Effects: ModerateModerateModerateModerateModerate
    • Adherence: AlwaysAlwaysAlwaysAlwaysAlways
    • Burden: Not at allNot at allNot at allNot at allNot at all
    added a treatment evaluation for Phenazopyridine from Feb 28, 2012 Mar 05, 2012
  6. Unicat
    Stopped treatment
    Phenazopyridine
    • Stopped: Feb 28, 2012
    • Reason: Course of treatment ended
    stopped taking the treatment Phenazopyridine Mar 05, 2012
  7. Unicat
    New evaluation
    Nitrofurantoin Treatment Evaluation
    • Efficacy for UTI (Urinary Tract Infection): Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major
    • Side Effects: ModerateModerateModerateModerateModerate
    • Adherence: AlwaysAlwaysAlwaysAlwaysAlways
    • Burden: Not at allNot at allNot at allNot at allNot at all
    added a treatment evaluation for Nitrofurantoin from Mar 4, 2012 Mar 05, 2012
  8. Unicat
    Stopped treatment
    Nitrofurantoin
    • Stopped: Mar 4, 2012
    • Reason: Course of treatment ended
    stopped taking the treatment Nitrofurantoin Mar 05, 2012
  9. Unicat
    Added
    Symptom Update
    • none UTI symptoms
    updated heryour symptoms for Mar 5, 2012 Mar 05, 2012
  10. Unicat
    Added
    Symptom Update
    • none UTI symptoms
    updated heryour symptoms for Mar 1, 2012 Mar 05, 2012
  11. Unicat
    Added
    Symptom Update
    • moderate UTI symptoms
    updated heryour symptoms for Feb 23, 2012 Mar 05, 2012
  12. Unicat
    Added treatment
    Hair, Skin and Nails
    • Started: Dec 26, 2011
    • Dosage: 1 cap(s) daily
    • Purpose: Hair, Brittle nails, and Thin nails (ie bendable or easily tearable)
    added the treatment Hair, Skin and Nails Feb 26, 2012
  13. Unicat
    Added treatment
    L-Arginine
    • Started: Dec 26, 2011
    • Dosage: 2000 mg daily
    • Purpose: General health
    added the treatment L-Arginine Feb 26, 2012
  14. Unicat
    Added condition
    UTI (Urinary Tract Infection)
    • First symptom: ?
    • Diagnosis: ?
    added the condition UTI (Urinary Tract Infection) Feb 26, 2012
  15. Unicat
    Added treatment
    Phenazopyridine
    • Started: Feb 26, 2012
    • Dosage: 600 mg daily
    • Purpose: UTI (Urinary Tract Infection)
    added the treatment Phenazopyridine Feb 26, 2012
  16. Unicat
    Added treatment
    Nitrofurantoin
    • Started: Feb 26, 2012
    • Dosage: 150 mg daily
    • Purpose: UTI (Urinary Tract Infection)
    added the treatment Nitrofurantoin Feb 26, 2012
  17. Unicat
    Stopped treatment
    Estradiol
    • Stopped: Jan 15, 2012
    • Reason: Course of treatment ended
    stopped taking the treatment Estradiol Feb 18, 2012
  18. Unicat
    Weight
    195 lb
    BMI
    32.4
    updated heryour weight for Feb 18, 2012 Feb 18, 2012
  19. Unicat
    MSRS
    67
    • Moderate Cognition
    • Mild Vision
    • Mild Speech
    • Moderate Swallowing
    • Moderate Upper Limb
    • Moderate Walking
    • Moderate Sensation
    completed the MSRS survey for Feb 18, 2012 Feb 18, 2012
  20. Unicat
    New evaluation
    Natalizumab Treatment Evaluation
    • Efficacy for MS (Multiple Sclerosis): ?Can't tell
    • Side Effects: ModerateModerateModerateModerateModerate
    • Adherence: AlwaysAlwaysAlwaysAlwaysAlways
    • Burden: SomewhatSomewhatSomewhatSomewhatSomewhat
    added a treatment evaluation for Natalizumab Feb 18, 2012
  21. Show more